Label: VARDENAFIL tablet, orally disintegrating

Bayer's patent for Levitra expired in 2018, allowing generic manufacturers to enter multiple markets.

This reduced prices by an estimated 40–60%, impacting branded sales.

Important Notes

The maximum dose should not exceed 10 mg. Severe hepatic dysfunction (Child-Pugh C): Use should be avoided. Comment: The orally disintegrating tablets should not be used in patients with moderate (Child-Pugh B) or severe (Child-Pugh C) hepatic dysfunction. If taking potent or moderate inhibitors of CYP450 3A4, the dose should be adjusted as follows: Ritonavir: No more than 2.5 mg in a 72-hour period Indinavir, saquinavir, atazanavir, ketoconazole 400 mg daily, itraconazole 400 mg daily, clarithromycin: No more than 2.5 mg in a 24-hour period Ketoconazole 200 mg daily, itraconazole 200 mg daily, erythromycin: No more than 5 mg in a 24-hour period Safety and efficacy have not been established in patients younger than 18 years. This drug is not indicated for use in pediatric patients.

Subscribe to MedicineNet's Men's Health Newsletter

This drug can be taken with or without food. The 10 mg orally disintegrating tablet (ODT) provides higher systemic exposure and is not interchangeable with the 10 mg film-coated tablets. The ODT tablet should be taken without liquid and immediately upon removal from the blister. Patients who require a lower or higher dose than 10 mg should be prescribed the film-coated tablets. Patients treated with alpha-blockers, who have previously used vardenafil film-coated tablets, may be switched to ODT tablets at the advice of their healthcare provider.

Medications & Supplements

Patients should stop use of PDE5 inhibitors, including this drug, and seek medical attention in the event of sudden loss of vision in one or both eyes, pills to get her in the mood instantly and decrease or loss of hearing. Symptoms related to postural hypotension may occur, appropriate countermeasures are recommended. Contact the prescribing physician if other antihypertensive drugs or new medications that may interact with this drug are prescribed by another healthcare provider. Patients should contact their healthcare provider for dose modification if they are not satisfied with the quality of their sexual performance with this drug, or in the case of an unwanted side effect. Vardenafil hydrochloride is a phosphodiesterase type 5 (PDE5) inhibitor approved primarily for erectile dysfunction (ED). The expiration facilitated increased accessibility and expanded the patient base, especially in emerging markets. In the US, the final patent expiration occurred in 2020. The European patent expired in 2017, leading to a surge in generic imports. Patent cliffs across major markets significantly shifted revenue streams, transitioning from branded dominance to a generics-focused market.

The drug's pharmacology remains stable with a half-life of 4–5 hours, allowing for flexible dosing. It competes with tadalafil (Cialis) and sildenafil (Viagra), which have similar efficacy but differ in duration and side effect profile.

• Vardenafil is ineffective without sexual arousal.
• It does not protect against sexually transmitted infections.
• Avoid excessive mental or physical exertion while on medication.
• Consult a healthcare professional if unsure about interactions.
• Don't take vardenafil if you've had recent heart attack.
• Use with caution if you have a bleeding disorder.
• Medication may cause a temporary drop in blood pressure.
• Avoid using if you have a known hypersensitivity.
• The pill should be taken as part of a treatment plan.
• Keep track of how you respond to the medication.

Commercially, the ED market is expanding due to increasing prevalence related to aging populations and rising awareness. The global aging demographic is expected to increase ED prevalence from 10% to 30% in men aged 40–70. Market growth is driven by increased focus on sexual health, over-the-counter availability in some regions, and newer formulations improving patient adherence.

Why is a prescription required for erectile dysfunction medicines?

It is marketed under brand names such as Levitra and Staxyn. Globally, the ED treatment market has valued approximately $4 billion in 2022. The segment including vardenafil accounts for roughly 20% of this market, with an estimated revenue of $800 million in 2022. Key manufacturers include Bayer, Teva Pharmaceuticals, and Sun Pharma. The generic segment's share increased from 15% in 2015 to over 50% by 2022, driven by patent expirations and regional generics proliferation. The popularity of combination therapies and the rise of telemedicine further influence demand dynamics.

Projection estimates forecast the ED market reaching over $6.5 billion globally by 2028, with vardenafil contributing approximately 15–20% of this value. Compound annual growth rate (CAGR) calculations suggest a 5–6% growth from 2023 to 2028, primarily propelled by: Expansion into emerging markets (Asia-Pacific, Latin America) Increased acceptance of generics, reducing patient costs Rise in over-the-counter product availability Technological innovations in formulation (e.g., fast-dissolving tablets) Regional variations could influence market share: North America is expected to be the dominant segment, but Asia-Pacific will witness the fastest growth, with a CAGR near 8%, due to higher prevalence and lower treatment access costs. Manufacturing costs for vardenafil have declined due to economies of scale and global production. Generic production costs are estimated at $0.10–$0.15 per pill, compared to branded formulations at $1.00–$2.00, creating profit margins of 85–90% for generics. Regulatory harmonization reduces approval timelines and cost, fostering quicker market entry.

Countries with streamlined approval processes, such as India and Brasil, enable faster revenue realization.

Trending on Pharmacy Times

If you have any questions about an open survey, please contact memberservices@. The FDA has approved a new generic equivalent to Levitra for erectile dysfunction. Officials with the FDA have approved the Abbreviated New Drug Application (ANDA) for Alembic’s Vardenafil Hydrochloride Tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg. The drug is indicated for the treatment of erectile dysfunction.1 According to Alembic, the approved ANDA is therapeutically equivalent to Bayer’s vardenafil hydrochloride (Levitra) tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.1 Vardenafil hydrochloride tablets were developed by GlaxoSmithKline and Bayer, and approved by the FDA in 2003.2 Vardenafil hydrochloride tablet have an estimated market size of $35 billion for 12 months ending June 2020, according to data obtained by Alembic.1 Alembic Pharmaceuticals Receives USFDA Final Approval for Vardenafil Hydrochloride Tablets, 2.5 mg (base), 5 mg (base), 10 mg (base), and 20 mg (base) [news release]. Some Branded Drugs Going Generic in 2018.

Who should not take vardenafil?

Applies to the following strengths: 2.5 mg; 5 mg; 10 mg; 20 mg Initial dose: 10 mg orally once a day, as needed, approximately 60 minutes before sexual activity. Increase to 20 mg or decrease to 5 mg based on efficacy and tolerability. Maximum dose: 20 mg once a day Initial dose: 5 mg orally once a day Sexual stimulation is required for a response to treatment. A time interval between dosing should be considered when administering this drug concomitantly with alpha-blockers. Patients taking alpha-blockers should not initiate vardenafil therapy with the orally disintegrating tablet.

Are you currently using Vardenafil (Levitra, Staxyn)?

Initial dose: 5 mg orally once a day, as needed, approximately 60 minutes before sexual activity Comments: Sexual stimulation is required for a response to treatment. CrCl: 30 to 80 mL/min: No adjustment recommended. Comment: The orally disintegrating tablet (brand Staxyn) can be used in patients with mild, moderate or severe renal impairment. Mild hepatic dysfunction (Child-Pugh A): No adjustment recommended. Moderate hepatic dysfunction (Child-Pugh B): 5 mg orally once a day, as needed, approximately 60 minutes before sexual activity. Conversely, stringent regulations in the US and EU can delay launches, impacting short-term revenue but fostering long-term stability. Pricing policies vary, with government-mandated price caps in several markets influencing profit margins. For instance, India enforces prices 30–40% lower than international reference prices, reducing profit potential but increasing volume sales.

• Vardenafil 10 mg is a popular choice for ED treatment.
• Dose can be adjusted by a healthcare provider.
• Avoid using vardenafil with recreational drugs like poppers.
• Do not use after consuming large amounts of alcohol.
• The pill is generally taken before planned intercourse.
• Its effects are dose-dependent and subject to individual variation.
• Adherence to prescribed dose helps prevent adverse effects.
• The medication can be used long-term if prescribed.
• Regular checkups can help monitor effectiveness and safety.
• Never double the dose if the first does not work immediately.

Generic vardenafil dominates due to patent expiry, with leading players capturing over 60% of the accessible market: Teva Pharmaceuticals: Largest global producer with extensive distribution channels.

• Vardenafil 10 mg tablets treat erectile dysfunction in men.
• The medication works by increasing blood flow to the penis.
• Take vardenafil 10 mg about 30 minutes before activity.
• It can be taken with or without food, but high-fat meals may delay effects.
• Maximum recommended dose is one tablet per 24 hours.
• Vardenafil may cause side effects like headache or flushing.
• Do not use vardenafil if you take nitrates for chest pain.
• Consult a doctor before using vardenafil if you have heart problems.
• Store vardenafil tablets at room temperature, away from moisture.
• Alcohol can increase side effects of vardenafil.

Sun Pharma: Focused on Asian markets, rapidly expanding in Latin America.

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

The service is available to members of your household who are 18 years old and older. If further counseling is needed, the counselor may refer you or your household members to relevant community resources. 6UPMC Health Plan members who are in Pennsylvania at the time of a virtual visit may select a UPMC-employed provider, subject to availability and discretion of the provider. Members located outside of Pennsylvania at the time of service or those who select Talk Therapy or Psychiatry services will receive care from a provider employed or contracted by Online Care Network II PC (OCN), also known as Amwell Medical Group. OCN is not an affiliate of UPMC.

How is vardenafil supplied (dosage forms)?

Limitations may apply for members of ASO plans that have opted out of coverage. Providers are not available to treat members who are in Puerto Rico. Privacy Statement & HIPAA Forms Terms & ConditionsCopyright 2026. COGR also signed on to a broader research community letter led by ACE raising similar concerns. COGR provides this compilation of resources, many developed by COGR, explaining Facilities and Administrative (F&A/Indirect) costs, the importance of these… COGR brings together the nation’s top research institutions to advocate for sound policies, streamline compliance, and strengthen the U.S.

Pregnancy Categories

research enterprise. COGR represents over 230 of the most research-intensive institutions in the U.S., providing expert policy advocacy and a strong voice on the financial and regulatory issues that impact research. Members gain access to timely insights, collaboration opportunities, and a national community of research leaders. COGR surveys its member institutions throughout the year to gather essential data and insights on topics of particular interest to the academic research community, which helps to support COGR’s advocacy efforts. In addition to these policy topic surveys, COGR also has a Volunteer Survey, open year round, so that representatives from member institutions can note their areas of expertise and their interest in engaging in various volunteer opportunities with COGR. Mylan: Active in the US and Europe with competitive pricing.